Dthera Sciences Announces Exclusivity Period and Option Agreement for its Digital Therapeutic in the Japanese Market
SAN DIEGO, CA / ACCESSWIRE / February 25, 2019 / Dthera™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized...
PRC Pairs Workforce Wellbeing Measurement With Frontline Workshops in AP3-Exclusive Package